Lactobacillus plantarum DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate Immunity

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Park, Min Kyung ^a,b   NGO, Vu ^b   Kwon, Young Man ^b   Lee, Young Tae ^b   Yoo, Sieun ^b   Cho, Young Hee ^c   Hong, Sung Moon ^c   Hwang, Hye Suk ^b   Ko, Eun Ju ^b   Jung, Yu Jin ^b   Moon, Dae Won ^d   Jeong, Eun Ji ^d   Kim, Min Chul ^b,e   Lee, Yu Na ^b   Jang, Ji Hun ^d   Oh, Joon Suk ^d   Kim, Cheol Hyun ^c   Kang, Sang Moo ^b  

^a Chungwoon University   (South Korea)

^b GEORGIA STATE UNIVERSITY   (United States)

^c Dankook University   (South Korea)

^d Tobico Inc Chungnam Techno Park   (South Korea)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CELL LOSS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE MODEL; DRUG EFFICACY; FEMALE; FERMENTED PRODUCT; HISTOPATHOLOGY; IMMUNOMODULATION; INFLUENZA A; INNATE IMMUNITY; LACTOBACILLUS PLANTARUM; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; VIRUS LOAD; WEIGHT REDUCTION;

ANIMALS; BONE MARROW CELLS; BRONCHOALVEOLAR LAVAGE FLUID; DENDRITIC CELLS; FEMALE; IMMUNITY, INNATE; INFLUENZA A VIRUS; INTERFERON-GAMMA; INTERLEUKIN-12; LACTOBACILLUS PLANTARUM; MICE; PROBIOTICS;

EID: 84885024680     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075368     Document Type: Article

References (54)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004) Influenza-associated hospitalizations in the United States. JAMA 292: 1333-1340.
2. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
3. Jones M, Del Mar C, (2006) Safety of neuraminidase inhibitors for influenza. Expert Opin Drug Saf 5: 603-608.
4. Oxford JS, (2007) Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza Other Respi Viruses 1: 27-34.
5. Beigel J, Bray M, (2008) Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 78: 91-102.
6. Long JK, Mossad SB, Goldman MP, (2000) Antiviral agents for treating influenza. Cleve Clin J Med 67: 92-95.
7. Moscona A, (2005) Oseltamivir resistance-disabling our influenza defenses. N Engl J Med 353: 2633-2636.
8. Gorbach SL, (1990) Lactic acid bacteria and human health. Ann Med 22: 37-41.
9. Hanniffy S, Wiedermann U, Repa A, Mercenier A, Daniel C, et al. (2004) Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol 56: 1-64.
10. Drouault S, Corthier G, (2001) [Health effects of lactic acid bacteria ingested in fermented milk]. Vet Res 32: 101-117.
11. Parvez S, Malik KA, Ah Kang S, Kim HY, (2006) Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 100: 1171-1185.
12. Nomura M, Kobayashi M, Narita T, Kimoto-Nira H, Okamoto T, (2006) Phenotypic and molecular characterization of Lactococcus lactis from milk and plants. J Appl Microbiol 101: 396-405.
13. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, et al. (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73: 386S-392S.
14. Corr SC, Gahan CG, Hill C, (2007) Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol 50: 380-388.
15. Youn HN, Lee DH, Lee YN, Park JK, Yuk SS, et al. (2012) Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res 93: 138-143.
16. Fujiwara D, Inoue S, Wakabayashi H, Fujii T, (2004) The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 135: 205-215.
17. Masuda S, Yamaguchi H, Kurokawa T, Shirakami T, Tsuji RF, et al. (2008) Immunomodulatory effect of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi grown in high-salt medium. Int J Food Microbiol 121: 245-252.
18. Nagao F, Nakayama M, Muto T, Okumura K, (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64: 2706-2708.
19. Ishida Y, Nakamura F, Kanzato H, Sawada D, Hirata H, et al. (2005) Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 88: 527-533.
20. Makino S, Ikegami S, Kume A, Horiuchi H, Sasaki H, et al. (2010) Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr 104: 998-1006.
21. Nagai T, Makino S, Ikegami S, Itoh H, Yamada H, (2011) Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice. Int Immunopharmacol 11: 2246-2250.
22. Kobayashi N, Saito T, Uematsu T, Kishi K, Toba M, et al. (2011) Oral administration of heat-killed Lactobacillus pentosus strain b240 augments protection against influenza virus infection in mice. Int Immunopharmacol 11: 199-203.
23. Maeda N, Nakamura R, Hirose Y, Murosaki S, Yamamoto Y, et al. (2009) Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol 9: 1122-1125.
24. Hori T, Kiyoshima J, Shida K, Yasui H, (2002) Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol 9: 105-108.
25. Yasui H, Kiyoshima J, Hori T, (2004) Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 11: 675-679.
26. Harata G, He F, Hiruta N, Kawase M, Kubota A, et al. (2010) Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol 50: 597-602.
27. Hori T, Kiyoshima J, Shida K, Yasui H, (2001) Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin Diagn Lab Immunol 8: 593-597.
28. Izumo T, Maekawa T, Ida M, Noguchi A, Kitagawa Y, et al. (2010) Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int Immunopharmacol 10: 1101-1106.
29. Youn HN, Lee YN, Lee DH, Park JK, Yuk SS, et al. (2012) Effect of intranasal administration of Lactobacillus fermentum CJL-112 on horizontal transmission of influenza virus in chickens. Poult Sci 91: 2517-2522.
30. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, et al. (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79: 14933-14944.
31. Bosio CM, Dow SW, (2005) Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol 175: 6792-6801.
32. McGill J, Van Rooijen N, Legge KL, (2008) Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med 205: 1635-1646.
33. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, et al. (2008) Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infection and immunity 76: 5843-5852.
34. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
35. Wang S, Le TQ, Kurihara N, Chida J, Cisse Y, et al. (2010) Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. The Journal of infectious diseases 202: 991-1001.
36. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
37. Van Reeth K, (2000) Cytokines in the pathogenesis of influenza. Vet Microbiol 74: 109-116.
38. Kawashima T, Hayashi K, Kosaka A, Kawashima M, Igarashi T, et al. (2011) Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses. Int Immunopharmacol 11: 2017-2024.
39. Evrard B, Coudeyras S, Dosgilbert A, Charbonnel N, Alame J, et al. (2011) Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One 6: e18735.
40. Weiss G, Rasmussen S, Zeuthen LH, Nielsen BN, Jarmer H, et al. (2010) Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 131: 268-281.
41. Cho YH, Hong SM, Kim CH, (2013) Isolation and Characterization of Lactic Acid Bacteria from Kimchi, Korean Traditional Fermented Food to Apply into Fermented Dairy Products. Korean J Food Sci An 33: 75-82.
42. Quan FS, Huang C, Compans RW, Kang SM, (2007) Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 81: 3514-3524.
43. Song JM, Van Rooijen N, Bozja J, Compans RW, Kang SM, (2011) Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc Natl Acad Sci U S A 108: 757-761.
44. Song JM, Wang BZ, Park KM, Van Rooijen N, Quan FS, et al. (2011) Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS One 6: e14538.
45. Kim MC, Song JM, Kwon YM, Lee YJ, et al. (2013) Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus. Mol Ther 21: 485-492.
46. Wen HS, Wang SP, (1959) Mouse adaptation of the Asian influenza virus. The Journal of infectious diseases 105: 9-17.
47. Van Rooijen N, Sanders A, (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93.
48. Thepen T, McMenamin C, Oliver J, Kraal G, Holt PG, (1991) Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur J Immunol 21: 2845-2850.
49. Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, et al. (2007) Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J Virol 81: 13710-13722.
50. Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, et al. (2010) Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol 84: 1110-1123.
51. Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, et al. (2011) Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. Journal of virology 85: 5782-5793.
52. Joo HG, (2003) Altered maturation of dendritic cells by taxol, an anticancer drug. Journal of veterinary science 4: 229-234.
53. Kim MH, Byon YY, Ko EJ, Song JY, Yun YS, et al. (2009) Immunomodulatory activity of ginsan, a polysaccharide of panax ginseng, on dendritic cells. Korean J Physiol Pharmacol 13: 169-173.
54. Kim MH, Joo HG, (2008) Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells. Immunology letters 115: 138-143.